Epigral Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Kaushal Soparkar
Chief executive officer
₹8.0m
Total compensation
| CEO salary percentage | 100.00% |
| CEO tenure | 9.5yrs |
| CEO ownership | 0.5% |
| Management average tenure | no data |
| Board average tenure | 9yrs |
Recent management updates
Recent updates
Epigral Limited Just Missed Earnings - But Analysts Have Updated Their Models
Nov 13
If EPS Growth Is Important To You, Epigral (NSE:EPIGRAL) Presents An Opportunity
Nov 11Epigral (NSE:EPIGRAL) Has A Pretty Healthy Balance Sheet
Sep 28Epigral Limited Just Recorded A 98% EPS Beat: Here's What Analysts Are Forecasting Next
Aug 06Epigral Limited (NSE:EPIGRAL) Might Not Be As Mispriced As It Looks
Jul 30Investors Should Be Encouraged By Epigral's (NSE:EPIGRAL) Returns On Capital
Jun 02Subdued Growth No Barrier To Epigral Limited (NSE:EPIGRAL) With Shares Advancing 25%
Apr 03Calculating The Fair Value Of Epigral Limited (NSE:EPIGRAL)
Feb 28
Doubling CPVC And ECH Production Will Strengthen Future Prospects
Epigral is expanding production capacity and focusing on high-margin value-added products to enhance earnings and future growth.Here's Why Epigral (NSE:EPIGRAL) Has Caught The Eye Of Investors
Dec 18Epigral Limited's (NSE:EPIGRAL) Shares Leap 29% Yet They're Still Not Telling The Full Story
Jul 04Epigral Limited (NSE:EPIGRAL) Looks Just Right With A 27% Price Jump
Apr 19Epigral Limited (NSE:EPIGRAL) Soars 28% But It's A Story Of Risk Vs Reward
Feb 23Epigral (NSE:EPIGRAL) Might Be Having Difficulty Using Its Capital Effectively
Feb 21Capital Investment Trends At Meghmani Finechem (NSE:MFL) Look Strong
Apr 05With EPS Growth And More, Meghmani Finechem (NSE:MFL) Makes An Interesting Case
Sep 28Meghmani Finechem's (NSE:MFL) Promising Earnings May Rest On Soft Foundations
May 03Meghmani Finechem Limited's (NSE:MFL) Business Is Yet to Catch Up With Its Share Price
Nov 22CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | ₹4b |
| Jun 30 2025 | n/a | n/a | ₹4b |
| Mar 31 2025 | ₹8m | ₹8m | ₹4b |
| Dec 31 2024 | n/a | n/a | ₹3b |
| Sep 30 2024 | n/a | n/a | ₹3b |
| Jun 30 2024 | n/a | n/a | ₹3b |
| Mar 31 2024 | ₹44m | ₹4m | ₹2b |
| Dec 31 2023 | n/a | n/a | ₹2b |
| Sep 30 2023 | n/a | n/a | ₹2b |
| Jun 30 2023 | n/a | n/a | ₹3b |
| Mar 31 2023 | ₹62m | ₹4m | ₹4b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹4b |
| Jun 30 2022 | n/a | n/a | ₹3b |
| Mar 31 2022 | ₹32m | ₹4m | ₹3b |
| Mar 31 2021 | ₹30m | ₹3m | ₹1b |
| Mar 31 2020 | ₹28m | ₹4m | ₹1b |
| Mar 31 2019 | ₹64m | ₹4m | ₹2b |
Compensation vs Market: Kaushal's total compensation ($USD89.63K) is below average for companies of similar size in the Indian market ($USD404.94K).
Compensation vs Earnings: Kaushal's compensation has been consistent with company performance over the past year.
CEO
Kaushal Soparkar (42 yo)
Mr. Kaushal Ashisbhai Soparkar serves as Chief Executive Officer and until August 5, 2023 served as Managing Director and serves as Director of Epigral Limited (formerly known as Meghmani Finechem Limited)...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 9.5yrs | ₹7.95m | 7.53% ₹ 4.9b | |
| CEO & Executive Director | 9.5yrs | ₹7.95m | 0.51% ₹ 334.2m | |
| Independent Non-Executive Director | 4.5yrs | ₹775.00k | no data | |
| Non-Executive Non-Independent Director | 9.5yrs | no data | 1.68% ₹ 1.1b | |
| Independent Non-Executive Director | 4.5yrs | ₹450.00k | no data | |
| Non-Executive Non-Independent Director | 9.5yrs | no data | 5.41% ₹ 3.5b | |
| Independent Non-Executive Director | 8.5yrs | ₹950.00k | no data | |
| Non-Executive Non-Independent Director | 9.5yrs | no data | 2.29% ₹ 1.5b | |
| Independent Non-Executive Woman Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 4.5yrs | ₹400.00k | 0.010% ₹ 6.5m |
Experienced Board: EPIGRAL's board of directors are considered experienced (9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/14 19:54 |
| End of Day Share Price | 2025/11/14 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Epigral Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | BP Wealth Management Private Limited |
| null null | Emkay Global Financial Services Ltd. |
| Meet Vora | Emkay Global Financial Services Ltd. |